跳至主要内容
临床试验/NCT07411261
NCT07411261尚未招募不适用

PremaBiom: Metatranscriptomics of the Respiratory Microbiome to Predict the Occurrence of Bronchopulmonary Dysplasia in Preterm Infants

University Hospital, Caen6 个研究点 分布在 1 个国家目标入组 270 人开始时间: 2026年3月1日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
尚未招募
入组人数
270
试验地点
6
主要终点
Diagnosis of bronchopulmonary dysplasia

研究概览

简要总结

The goal of this clinical trial is to understand the impact of respiratory microbiome maturation in respiratory health of preterm infants under 32 gestational weeks. The main questions it aims to answer are:

  • What is the role of microbiome maturation in respiratory health (development of bronchopulmonary dysplasia, childhood asthma and viral respiratory infections) of preterm infants ?
  • Which environmental or health factors are involved in the maturation of the respiratory microbiome ?

Participants will undergo follow-up from birth until 3 years of corrected age including nasal swabs, stool samples, and for some of them blood and milk sample.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Screening
盲法
None

入排标准

年龄范围
— 至 72 Hours(Child)
性别
All
接受健康志愿者

入选标准

  • Preterm infants with gestational age at birth lower than 32 gestational weeks and 6 days.
  • Hospital stay in one of the participant neonatal care units
  • Infants covered by the social security system of at least one of their parents
  • Whose parents have been informed about the study and agree to sign the informed consent form

排除标准

  • Palliative care only
  • Lack of parental consent
  • Parents who are minors or under legal protection (guardianship, conservatorship, judicial protection)
  • Parents who do not speak French

研究组 & 干预措施

Observational arm

Other

This is a cohort of preterm infants, the interventions provided additionally to standard care are biological sampling (nasal swab, stool, blood and milk).

干预措施: Nasal swab (Biological)

Observational arm

Other

This is a cohort of preterm infants, the interventions provided additionally to standard care are biological sampling (nasal swab, stool, blood and milk).

干预措施: blood sampling (Biological)

Observational arm

Other

This is a cohort of preterm infants, the interventions provided additionally to standard care are biological sampling (nasal swab, stool, blood and milk).

干预措施: Mother milk sampling (Biological)

Observational arm

Other

This is a cohort of preterm infants, the interventions provided additionally to standard care are biological sampling (nasal swab, stool, blood and milk).

干预措施: Stool sampling (Biological)

结局指标

主要结局

Diagnosis of bronchopulmonary dysplasia

时间窗: 36 gestational weeks

At 36 gestational weeks, bronchopulmonary dysplasia (BPD) will be retained if any ventilatory support (invasive, non invasive, high or low flow oxygen) is required at least 23h over 24. This definition is based on the Jobe 2001 criteria for BPD diagnosis moderate or severe.

次要结局

  • Multidimensional analysis of microbiome profiles(At birth, 32 GW (gestational weeks), 36 GW and 4 months of corrected age.)
  • Bronchopulmonary dysplasia severity(36 gestational weeks)
  • Viral detection(At birth, 32 GW (gestational weeks), 36 GW and 4 months of corrected age.)
  • Viral infections or bronchiolitis during childhood(1, 2, 4, 8, 12, 18, 24 and 36 months of corrected age.)
  • Preschool asthma(Up to 36 months of corrected age.)
  • Cellular RNA expression in peripherical blood(36 gestational weeks)

研究者

申办方类型
Other
责任方
Sponsor

研究点 (6)

Loading locations...

相似试验